V. Majerciak et al., Increased virulence of Marek's disease virus type 1 vaccine strain CVI988 after adaptation to QT35 cells, ACT VIROLOG, 45(2), 2001, pp. 101-108
CVI988/Rispens strain of Marek's disease virus type 1 (MDV-1) is widely use
d as efficient vaccine to control Marek's disease (MD) in chicken flocks. S
imilarly to other live MD vaccine viruses it is propagated in freshly prepa
red chicken embryo fibroblasts (CEF). In this study, MDV-1 CVI988/Rispens s
train was adapted to QT35 cells. The adapted virus, designated QT-CVI, exhi
bited similar cytopathic effect (CPE) in vitro to that of parental virus pr
opagated in CEF. In contrast, QT-CVI induced MD symptoms typical for mild M
DV-1 strains after injection to birds. For identification of differentially
expressed transcripts that might be involved in increased virulence of QT-
CVI, we performed subtractive suppression hybridization (SSH). Subtracted P
CR products mapped within MDV-1 BamHI-A and -H fragments and differential g
ene expression was also confirmed by Northern blot analysis with probes der
ived from these regions. To examine possible divergence at the virus genome
level, PCR analysis was carried out. The BamHI-H fragment-specific 132 bp
repeats were present at variable copy number, ranging from 2 to more than 3
0 copies in both CVI988/Rispens and QT-CVI DNAs. PCR assays with primers ma
pping at the U-S/IRS junction identified CVI988/Rispens-specific insertion
of 116 bp in the region upstream of the ICP4 open reading frame (ORF). PCR
analysis was positive also for DNA from non-infected QT35 cells and was con
sistent with the observation of Yamaguchi et al. (J Virol. 74, 10176-10186,
2000) who have found that QT35 cells carry a latent MDV-1 genome. It is li
kely, that adaptation of CVI988/Rispens to QT35 cells resulted in reactivat
ion of an endogenous MDV-1 or at least in induction of expression of virule
nce-related transcripts that have consequently led to QT-CVI pathogenicity
for chickens.